Clinical Trials Browser

Phase 2 × NIH × Thyrotropin Alfa × Clear all

NCT03841617 2026-02-17

The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer

Phase 2 Recruiting

Neoplasm Metastasis, Thyroid Neoplasms